Literature DB >> 9192095

Suppression of Helicobacter pylori urease activity by sucralfate and sulglycotide.

B L Slomiany1, J Piotrowski, A Slomiany.   

Abstract

The effect of gastroprotective agents, sucralfate and sulglycotide, on the in vitro activity of H. pylori urease was investigated. The bacterium was subjected to sonication, centrifuged, and the supernatant used as an enzyme source. The assays revealed that the rate of urea degradation was proportional to enzyme protein up to 100 micrograms and remained constant with time for 10 min. Introduction of sucralfate or sulglycotide to the assay system led to the reduction in the rate of ammonia production. With both drugs the optimal inhibition was attained at 10 micrograms/ml, at which dose a 63.1% decrease in urease activity occurred with sucralfate and a 70.2% inhibition was obtained with sulglycotide. The findings demonstrate that the inhibitory action of sucralfate and sulglycotide on H. pylori urease activity may be of value in the treatment of gastric disease associated with H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192095     DOI: 10.1080/15216549700202531

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  3 in total

1.  Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.

Authors:  Hajime Isomoto; Hisashi Furusu; Ken Ohnita; Chun-Yang Wen; Kenichiro Inoue; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

2.  Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice.

Authors:  Koichiro Watanabe; Kazunari Murakami; Ryugo Sato; Koji Kashimura; Masahiro Miura; Satoshi Ootsu; Hajime Miyajima; Masaru Nasu; Tadayoshi Okimoto; Masaaki Kodama; Toshio Fujioka
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Gastric mucosal inflammatory responses toHelicobacter pylori lipopolysaccharide: suppression of caspase-3 and nitric oxide synthase-2 by omeprazole and sucralfate.

Authors:  B L Slomiany; J Piotrowski; A Slomiany
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.